Summary:
Health systems are navigating one of the most challenging financial environments in recent memory. In Q2 2026, converging pressures — from rising labor and drug costs to Medicare underpayment, Medicare Advantage friction, and an impending coverage cliff — are squeezing margins from every direction. At the same time, sweeping policy changes are reshaping how care is paid for, with mandatory value-based payment models set to affect nearly every hospital in the country by 2027.
Yet amid the turbulence, health system technology investment is holding firm — and in many cases, growing. Based on a quantitative survey of senior technology executives at 31 leading U.S. health systems, this report from The Health Management Academy reveals where leaders are placing their bets, how AI adoption is evolving across clinical and operational categories, and what's really driving purchasing decisions in a compressed-margin climate.
The findings carry clear implications for industry partners. Decision-making authority is consolidating at the executive level. ROI expectations are tightening. And health system leaders are sending a direct message to vendors: understand our organization, prove your value, integrate into our workflows, and stay with us after the contract is signed.
Whether you're navigating an active sales cycle, refining your go-to-market strategy, or trying to anticipate where health system priorities are headed, this Q2 2026 Market Pulse offers the data and context you need to show up informed and ready.
Please log in to view the full recording and access downloadable materials.
Key takeaways:
1) Health system margins are under severe, multi-directional pressure Revenue and expense growth converged in 2025, wiping out prior year gains. Rising input costs, government underpayment, MA payer friction, and a looming coverage cliff are all hitting simultaneously — with the median YTD health system margin sitting at just 0.4% as of March 2026.
What this means for industry partners: The bar for ROI justification has never been higher. Partners must lead with concrete financial impact — cost reduction, revenue recovery, or administrative efficiency — and be prepared to prove it quickly. Solutions that directly address denied claims, uncompensated care, or mandatory value-based payment readiness have the clearest path to a conversation.
2) Technology budgets are growing, but decisions are consolidating at the top Despite financial pressure, most health systems — especially the largest — are increasing technology investment. However, CIOs are pulling decision-making authority closer, triggering sign-off on smaller contracts than ever before, and shortening agreement terms.
What this means for industry partners: Selling lower in the organization is becoming less effective. Partners need C-suite ready messaging, faster time-to-value narratives, and flexible contract structures. Getting to the CIO — and speaking their language — is no longer optional.
3) AI adoption is real but uneven, and health systems want partners, not just products AI is expanding beyond documentation into virtual care and care operations, but budget growth doesn't automatically mean AI investment. Leaders across all system sizes cite barriers ranging from regulatory concerns to unclear ROI — and openly say vendors need to better understand their workflows, prove measurable value, and stay engaged after implementation.
What this means for industry partners: Generic AI pitches are falling flat. Partners who invest in understanding the health system's specific workflows, tailor their ROI case to system size, and commit to post-implementation success will stand out in an increasingly crowded market.